<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Considerable interest has focused on the possibility of using <z:mp ids='MP_0001799'>viral</z:mp> vectors to deliver genes to the central <z:mp ids='MP_0008912'>nervous</z:mp> system for the purpose of decreasing necrotic neuronal injury </plain></SENT>
<SENT sid="1" pm="."><plain>To that end, we have previously shown that a <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus (HSV) vector expressing Bcl-2 could protect neurons from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In that study, vector was delivered before the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, for such gene therapy to be of clinical use, vectors must be protective even if delivered after the <z:hpo ids='HP_0003674'>onset</z:hpo> of the insult </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, we show that an HSV vector expressing Bcl-2 protects striatal neurons when delivered after focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Rats were exposed to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 1 hour, followed by reperfusion, and damage was assessed 48 hours later </plain></SENT>
<SENT sid="6" pm="."><plain>Delivery of the Bcl-2 vector 30 minutes after reperfusion (i.e., 1.5 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>) prevented any significant loss of virally-targeted neurons in the striatum </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, in rats microinfused with a vector only expressing a reporter gene, a highly significant loss of neurons occurred </plain></SENT>
<SENT sid="8" pm="."><plain>By 4 hours into the reperfusion period (5 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>), delivery of the Bcl-2 vector was no longer protective </plain></SENT>
<SENT sid="9" pm="."><plain>These data show the efficacy of postinsult gene therapy strategies for the brain, underline the finite length of this temporal therapeutic window, and support the growing evidence attesting to the neuroprotective potential of Bcl-2 </plain></SENT>
</text></document>